Table 1 Major bleeding event rates according to the bleeding risk scores.

From: Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores

 

Major Bleeding Investigator Level N = 162

Major Bleeding Adjudicated EventN = 127

 

Major Bleeding Investigator LevelN = 162

Major Bleeding Adjudicated EventN = 127

HAS-BLED N (%)

ATRIA N (%)

 0

1 (0.6)

1 (0.8)

 0

11 (6.8)

8 (6.3)

 1

7 (4.3)

3 (2.4)

 1

64 (39.5)

8 (37.8)

 2

28 (17.3)

23 (18.1)

 2

29 (17.9)

22 (17.3)

 3

48 (29.6)

31 (24.4)

 3

54 (33.3)

45 (35.4)

 4

43 (26.5)

41 (32.3)

 4

3 (1.9)

3 (2.4

 5

26 (16.0)

20 (15.7)

 5

0 (0.0)

0 (0.0)

 6

9 (5.6)

8 (6.3)

 6

1 (0.6)

1 (0.8)

HAS-BLED Risk N (%)

ATRIA Risk N (%)

 Low

36 (22.2)

27 (21.3)

 Low

158 (97.5)

123 (96.9)

 High

126 (77.8)

100 (78.7)

 Medium/High

4 (2.5)

4 (3.1

HAS-BLED Risk (per 100 patient-years)

ATRIA Risk (per 100 patient-years)

 Low

2.4

1.8

 Low

3.3

2.5

 High

3.6

2.9

 Medium/High

3.4

3.4

ORBIT N (%)

HEMORR2HAGES N (%)

 0

48 (29.6)

38 (29.9)

 0

9 (5.6)

6 (4.7)

 1

49 (30.2)

36 (28.3)

 1

81 (50.0)

60 (47.2)

 2

47 (29.0)

37 (29.1)

 2

45 (27.8)

39 (30.7)

 3

15 (9.3)

14 (11.0)

 3

22 (13.6)

17 (13.4)

 4

2 (1.2)

2 (1.6)

 4

4 (2.5)

4 (3.1)

 5

1 (0.6)

0 (0)

 5

1 (0.6)

1 (0.8)

ORBIT Risk N (%)

HEMORR2HAGES Risk N (%)

 Low

144 (88.9)

111 (87.4)

 Low

90 (55.6)

66 (52.0)

 Medium/High

18 (11.1)

16 (12.6)

 Medium/High

72 (44.4)

48 (48.0)

ORBIT Risk (per 100 patient-years)

HEMORR2HAGES Risk (per 100 patient-years)

 Low

3.1

2.4

 Low

3.0

2.2

 Medium/High

4.9

4.4

 Medium/High

3.6

2.4